Pathological and radiological features of false-positive lesions on [68Ga]Ga-PSMA-11 PET/CT in primary staging of prostate cancer: a radio-pathology matching analysis

被引:0
|
作者
Li, Renjie [1 ,2 ]
Fu, Yao [3 ]
Peng, Shan [3 ]
Yang, Fengjiao [4 ]
Ai, Shuyue [4 ]
Wang, Feng [4 ]
Zhang, Shun [1 ,2 ]
Guo, Hongqian [1 ,2 ]
Qiu, Xuefeng [1 ,2 ]
机构
[1] Nanjing Univ, Med Sch, Nanjing Drum Tower Hosp, Dept Urol,Affiliated Hosp, Nanjing 210008, Peoples R China
[2] Nanjing Univ, Inst Urol, Nanjing 210008, Peoples R China
[3] Nanjing Univ, Nanjing Drum Tower Hosp, Affiliated Hosp, Dept Pathol,Med Sch, Nanjing 210008, Peoples R China
[4] Nanjing Med Univ, Nanjing Hosp 1, Dept Nucl Med, Nanjing 210029, Peoples R China
基金
中国国家自然科学基金;
关键词
Ga-68]Ga-PSMA-11 PET/CT; Pathological feature; False-positive; True-negative; True-positive; MULTIPARAMETRIC MRI; EMISSION-TOMOGRAPHY; GA-68-PSMA PET/CT; PI-RADS; DIAGNOSIS; ACCURACY;
D O I
10.1007/s00259-025-07148-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose The aim of this study was to investigate the radiological and pathological characteristics of false-positive lesions on [Ga-68]Ga-PSMA-11 PET/CT during the primary staging of prostate cancer. Methods This study retrospectively analyzed 216 prostate cancer patients who had [Ga-68]Ga-PSMA-11 PET/CT before radical prostatectomy. False-positive lesion was defined as suspicious lesion with PRIMARY score >= 3 on PET/CT but benign on whole-mount pathology. To analyze the radiological and pathological features of false-positive lesions, no-uptake areas on PSMA PET/CT with benign pathology on the whole-mount specimen were randomly delineated and defined as true-negative lesions. The pathological features of false-positive and true-negative lesions were compared using Fisher's exact test. The differences of SUVmax and SUVmean between false-positive and true-positive lesions were determined and compared using the Wilcoxon matched-pairs signed-ranks test. In addition, PSMA expression in false-positive lesions was assessed by immunohistochemistry. Results A total of 36 false-positive lesions were identified on [Ga-68]Ga-PSMA-11 PET/CT: 25 (69.44%) were simple atrophy with cyst formation, 7 (19.44%) were prostatic nodular hyperplasia, 3 (8.33%) were inflammation and 1 (2.78%) was normal glands. A comparable number of 36 true-negative lesions were delineated: 21 (58.33%) were normal glands, 8 (22.22%) were simple atrophy with cyst formation, 6 (16.67%) were prostatic nodular hyperplasia, and 1 (2.78%) were inflammation. The Fisher's exact test revealed a statistically significant difference in the prevalence of simple atrophy with cyst formation between false-positive and true-negative lesions (69.44% vs. 22.22%; P < 0.001). Differences in SUVmax and SUVmean between false-positive and true-positive lesions were also statistically significant (both P < 0.001). PSMA expression in false-positive lesions was confirmed via immunohistochemistry. Conclusion This study determined that simple atrophy with cyst formation is a distinctive pathological feature of false-positive lesions on [Ga-68]Ga-PSMA-11 PET/CT. This observation is likely attributable to the elevated PSMA expression in simple atrophy with cyst formation, as confirmed by histological analysis. Additionally, false-positive lesions were found to have significantly lower SUV compared to true-positive lesions.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Dynamic patterns of [68Ga]Ga-PSMA-11 uptake in recurrent prostate cancer lesions
    Alberts, Ian
    Sachpekidis, Christos
    Gourni, Eleni
    Boxler, Silvan
    Gross, Tobias
    Thalmann, George
    Rahbar, Kambiz
    Rominger, Axel
    Afshar-Oromieh, Ali
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (01) : 160 - 167
  • [2] Prostate Cancer Biochemical Recurrence Resulted Negative on [68Ga]Ga-PSMA-11 but Positive on [18F]Fluoromethylcholine PET/CT
    Laudicella, Riccardo
    La Torre, Flavia
    Davi, Valerio
    Croce, Ludovica
    Arico, Demetrio
    Leonardi, Giuseppe
    Russo, Simona
    Minutoli, Fabio
    Burger, Irene A.
    Baldari, Sergio
    TOMOGRAPHY, 2022, 8 (05) : 2471 - 2474
  • [3] Interobserver agreement of [68Ga]Ga-PSMA-11 PET/CT images interpretation in men with newly diagnosed prostate cancer
    Derwael, Celine
    Lavergne, Olivier
    Lovinfosse, Pierre
    Nechifor, Vlad
    Salve, Mallory
    Waltregny, David
    Hustinx, Roland
    Withofs, Nadia
    EJNMMI RESEARCH, 2020, 10 (01)
  • [4] Digital versus analogue PET in [68Ga]Ga-PSMA-11 PET/CT for recurrent prostate cancer: a matched-pair comparison
    Alberts, Ian
    Prenosil, George
    Sachpekidis, Christos
    Weitzel, Thilo
    Shi, Kuangyu
    Rominger, Axel
    Afshar-Oromieh, Ali
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (03) : 614 - 623
  • [5] Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer
    Ghezzo, Samuele
    Mapelli, Paola
    Bezzi, Carolina
    Samanes Gajate, Ana Maria
    Brembilla, Giorgio
    Gotuzzo, Irene
    Russo, Tommaso
    Preza, Erik
    Cucchiara, Vito
    Ahmed, Naghia
    Neri, Ilaria
    Mongardi, Sofia
    Freschi, Massimo
    Briganti, Alberto
    De Cobelli, Francesco
    Gianolli, Luigi
    Scifo, Paola
    Picchio, Maria
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (08) : 2548 - 2560
  • [6] Standardization of the [68Ga]Ga-PSMA-11 Radiolabeling Protocol in an Automatic Synthesis Module: Assessments for PET Imaging of Prostate Cancer
    Fuscaldi, Leonardo L.
    Sobral, Danielle V.
    Durante, Ana Claudia R.
    Mendonca, Fernanda F.
    Miranda, Ana Claudia C.
    da Cunha, Marcelo L.
    Malavolta, Luciana
    Mejia, Jorge
    de Barboza, Marycel F.
    PHARMACEUTICALS, 2021, 14 (05)
  • [7] Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET/MRI
    Papp, L.
    Spielvogel, C. P.
    Grubmueller, B.
    Grahovac, M.
    Krajnc, D.
    Ecsedi, B.
    Sareshgi, R. A. M.
    Mohamad, D.
    Hamboeck, M.
    Rausch, I.
    Mitterhauser, M.
    Wadsak, W.
    Haug, A. R.
    Kenner, L.
    Mazal, P.
    Susani, M.
    Hartenbach, S.
    Baltzer, P.
    Helbich, T. H.
    Kramer, G.
    Shariat, S. F.
    Beyer, T.
    Hartenbach, M.
    Hacker, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (06) : 1795 - 1805
  • [8] Machine learning-based prediction of invisible intraprostatic prostate cancer lesions on 68 Ga-PSMA-11 PET/CT in patients with primary prostate cancer
    Yi, Zhilong
    Hu, Siqi
    Lin, Xiaofeng
    Zou, Qiong
    Zou, MinHong
    Zhang, Zhanlei
    Xu, Lei
    Jiang, Ningyi
    Zhang, Yong
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (05) : 1523 - 1534
  • [9] Incremental Impact of [68Ga]Ga-PSMA-11 PET/CT in Primary N and M Staging of Prostate Cancer Prior to Curative-Intent Surgery: a Prospective Clinical Trial in Comparison with mpMRI
    Szigeti, Florian
    Schweighofer-Zwink, Gregor
    Meissnitzer, Matthias
    Hauser-Kronberger, Cornelia
    Hitzl, Wolfgang
    Kunit, Thomas
    Forstner, Rosemarie
    Pirich, Christian
    Beheshti, Mohsen
    MOLECULAR IMAGING AND BIOLOGY, 2022, 24 (01) : 50 - 59
  • [10] Comparison of 18F-based PSMA radiotracers with [68Ga]Ga-PSMA-11 in PET/CT imaging of prostate cancer-a systematic review and meta-analysis
    Huang, Siyu
    Ong, Sean
    McKenzie, Dean
    Mirabelli, Adam
    Chen, David C.
    Chengodu, Thilakavathi
    Murphy, Declan G.
    Hofman, Michael S.
    Lawrentschuk, Nathan
    Perera, Marlon
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024, 27 (04) : 654 - 664